Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endothelial Vasomotricity After Nicotinic Acid in Recent Acute Coronary Syndrome
2006-005950-57Phase 3Active
- Sponsor
- Société Française de Cardiologie
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute coronary syndrome (ACS) comparing Niaspan with Placebo (2 arms). Primary endpoint: Variation of HDL levels. Started Feb 2007; status: active.
02
Drugs
niacin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2006-005950-57.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005950-57.